/  News

Statements

02 October 2024

Unitaid ready to invest immediately to support accelerated global access to lenacapavir

View More

25 September 2024

Donor statement on urgent action required to address antimalarial drug resistance

View More

13 September 2024

Unitaid renews call for clear access strategy after positive results from Gilead’s PURPOSE 2 lenacapavir trial

View More

21 August 2024

Mpox emergency response must prioritize access to diagnostics, clinical care and vaccines

View More

31 July 2024

Unitaid welcomes the Rio Declaration, which aims to advance health sovereignty and innovation in the Global South

View More

05 July 2024

Unitaid, IAVI, Medicines Patent Pool and Wellcome publish novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

View More

27 June 2024

In an open letter, Unitaid urges MSF to continue its critical work in advancing access for key health products

View More

27 June 2024

Global Fund and Unitaid Increase Collaboration to Advance Equitable Access to Health Products

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.